Oxford Nanopore Technologies (LON:ONT) Price Target Raised to GBX 300 at Royal Bank Of Canada

Oxford Nanopore Technologies (LON:ONT) had its price target increased by stock analysts at Royal Bank Of Canada from GBX 280 to GBX 300 in a report issued on Wednesday,Digital Look reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank Of Canada’s price target would suggest a potential upside of 94.62% from the stock’s previous close.

ONT has been the topic of a number of other reports. Berenberg Bank reiterated a “buy” rating and set a GBX 250 price objective on shares of Oxford Nanopore Technologies in a research note on Monday, January 12th. Peel Hunt reaffirmed a “hold” rating and set a GBX 153 price objective on shares of Oxford Nanopore Technologies in a report on Friday, December 5th. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, Oxford Nanopore Technologies has an average rating of “Moderate Buy” and an average target price of GBX 230.60.

Oxford Nanopore Technologies Stock Performance

Shares of ONT stock traded up GBX 3.65 during trading hours on Wednesday, reaching GBX 154.15. 17,735,906 shares of the company traded hands, compared to its average volume of 3,640,994. The company has a debt-to-equity ratio of 8.07, a current ratio of 4.45 and a quick ratio of 6.01. Oxford Nanopore Technologies has a 12-month low of GBX 88.60 and a 12-month high of GBX 224.80. The firm has a 50-day moving average price of GBX 133.93 and a 200 day moving average price of GBX 155.97. The company has a market cap of £1.49 billion, a P/E ratio of -10.42 and a beta of 0.80.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.